Bayer Secures 3.0 Billion Euros To Improve Capital Structure
10 July 2026, Leverkusen: Bayer has secured 3.0 billion euros in equity capital to improve its capital structure. The company signed a respective
Read MoreFind the latest news, research, product launches, financial results, investments, partnerships, regulatory developments, and business updates from Bayer. Stay informed on Crop Science, pharmaceuticals, consumer health, crop protection, seeds, biologicals, digital agriculture, healthcare, sustainability, and global business developments.
Bayer AG is a global life science company headquartered in Leverkusen, Germany, operating through three divisions: Crop Science, Pharmaceuticals, and Consumer Health. Its businesses develop products and technologies across agriculture and healthcare, with the company focused on addressing challenges related to food security, climate change, disease prevention, and healthcare access. Bayer’s global portfolio includes seeds, biotechnology traits, crop protection products, digital agriculture solutions, prescription medicines, and consumer healthcare brands.
The Crop Science division is particularly relevant to agriculture, with activities spanning seeds and traits, herbicides, fungicides, insecticides, biologicals, digital farming, and agricultural research. Bayer is advancing a pipeline of new agricultural products while focusing on technologies designed to improve farm productivity, resource efficiency, and resilience. Its current agricultural strategy includes a portfolio of ten planned blockbuster launches.
In India, Bayer has been present for more than 130 years and operates through businesses including Crop Science, Pharmaceuticals and Consumer Health. Bayer CropScience Limited is the group’s listed Indian Crop Science company, with activities covering crop protection, seeds, traits, biologicals and digital farming. The India Crop Science business works with more than 30 million smallholder farmers and focuses on crops including rice, corn, cotton, fruits and vegetables.
Bayer’s global developments in 2026 include Crop Science innovation, financial performance, product pipeline advancement, agricultural technology, sustainability, glyphosate litigation, and strategic investments. The company reported higher Crop Science sales and substantial earnings growth in both the first and second quarters of 2026.
This category features Bayer news, Crop Science, Bayer CropScience India, crop protection, seeds, herbicides, fungicides, insecticides, biologicals, digital agriculture, product launches, R&D, financial results, regulatory developments, sustainability, glyphosate, leadership, investments, partnerships, and global agriculture and healthcare developments.
10 July 2026, Leverkusen: Bayer has secured 3.0 billion euros in equity capital to improve its capital structure. The company signed a respective
Read More02 July 2026, Leverkusen: Bayer Group today announced the consolidation of the U.S. glyphosate business into Ruveon LLC to optimize and align
Read More01 July 2026, Washington: Bayer has asked the U.S. government to impose anti-dumping and countervailing duties on glyphosate imports from China, arguing
Read MoreGuest Author: Christian Pereira, Agribusiness Strategist at Bizup Strategy, specializing in growth strategies and M&A. 29 June 2026, São Paulo: Every major
Read More27 June 2026, Leverkusen: The U.S. Supreme Court issued a 7:2 landmark ruling in the Durnell Roundup™ case on Thursday, affirming that
Read More18 June 2026, Calgary: The Crop Science division of Bayer announced that Kacy Perry has been appointed the Country Division Head
Read More10 June 2026, New Delhi: Bayer’s Consumer Health division today announced the launch of Alka-Seltzer® in India, marking its entry into the
Read More03 June 2026, Mississauga: Bayer celebrates Jacqueline De Gagné, former Head of Law, Patents and Compliance (LPC) in Canada, on receiving the
Read More28 May 2026, Mumbai: Bayer CropScience Limited (BSE: 506285) on Tuesday announced its results for the financial year (FY) and quarter ended
Read More13 May 2026, Leverkusen: Bayer AG reported group sales of €13.4 billion in the first quarter of 2026, marking a 4 percent increase
Read More